According to Monte Rosa Therapeutics's latest financial reports the company's current earnings are ยฃ28.72 Million. In 2025 the company made an earning of -ยฃ30.05 Million, an increase over its 2024 earnings that were of -ยฃ53.05 Million. The earnings displayed on this page is the company's Pretax Income.